• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一般人群个体感染预防行为量表(IPBS-I)的编制与验证

Development and Validation of the Infection Prevention Behavior Scale of Individuals (IPBS-I) for the General Population.

作者信息

Heo Myoung-Lyun, Jang Yang-Min

机构信息

Department of Nursing Science, Jeonju University, Jeonju-si, Jeollabuk-do, South Korea.

Department of Nursing Science, Shinsung University, Dangjin, Chungcheongnam-do, South Korea.

出版信息

J Multidiscip Healthc. 2021 Oct 5;14:2791-2802. doi: 10.2147/JMDH.S334154. eCollection 2021.

DOI:10.2147/JMDH.S334154
PMID:34675528
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8502068/
Abstract

PURPOSE

This study aimed to develop a scale for measuring infection prevention behavior of individuals and to verify its validity and reliability for the general population.

PATIENTS AND METHODS

The scale items were selected using a literature review on the chain of infection and its content validity. There were 297 study participants, all of whom provided informed consent. Data were collected online from September 3 to September 8, 2020, using Google Survey in Korea. The scale's construct validity was verified through exploratory and confirmatory factor analyses, criterion validity was Pearson's Correlation, and reliability was tested using Cronbach's alpha.

RESULTS

Twelve items and three factors were selected after a factor and an exploratory factor analysis of 29 scale items. The three factors were pathogen blocking, transmission blocking, and immunity enhancement. A confirmatory factor analysis validated the model goodness of fit, and the convergent validity and discriminant validity of the scale were verified. The correlation coefficient with a scale for respiratory infection prevention practice was 0.69, thereby confirming the criterion validity of the scale. The reliability of the final scale (Cronbach's alpha) was 0.86.

CONCLUSION

This scale is reflective of the social features of the Korean adult population, and it is easy and concise to be administered to general public, making it useful for subsequent studies on infection prevention.

摘要

目的

本研究旨在开发一种用于测量个体感染预防行为的量表,并验证其在普通人群中的有效性和可靠性。

患者与方法

通过对感染链及其内容效度的文献综述来选择量表项目。共有297名研究参与者,他们均提供了知情同意书。2020年9月3日至9月8日,在韩国使用谷歌调查问卷在线收集数据。通过探索性和验证性因素分析来验证量表的结构效度,标准效度采用皮尔逊相关性分析,信度采用克朗巴哈系数进行检验。

结果

对29个量表项目进行因素分析和探索性因素分析后,筛选出12个项目和3个因素。这3个因素分别是病原体阻断、传播阻断和免疫力增强。验证性因素分析验证了模型的拟合优度,并验证了量表的收敛效度和区分效度。该量表与呼吸道感染预防实践量表的相关系数为0.69,从而证实了该量表的标准效度。最终量表的信度(克朗巴哈系数)为0.86。

结论

该量表反映了韩国成年人群的社会特征,易于向普通公众发放且简明扼要,有助于后续感染预防研究。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5ae/8502068/a4eef89859c1/JMDH-14-2791-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5ae/8502068/a4eef89859c1/JMDH-14-2791-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5ae/8502068/a4eef89859c1/JMDH-14-2791-g0001.jpg

相似文献

1
Development and Validation of the Infection Prevention Behavior Scale of Individuals (IPBS-I) for the General Population.一般人群个体感染预防行为量表(IPBS-I)的编制与验证
J Multidiscip Healthc. 2021 Oct 5;14:2791-2802. doi: 10.2147/JMDH.S334154. eCollection 2021.
2
Development of Respiratory Infection Prevention and Control Self-Efficacy Scale for Adults.成人呼吸道感染预防与控制自我效能量表的编制
J Multidiscip Healthc. 2024 Apr 30;17:1943-1952. doi: 10.2147/JMDH.S456939. eCollection 2024.
3
Development and Validation of a Scale Measuring the Post Pandemic-Health Promotion Behavior (PP-HPB) of Young Adults in the Digital Era.数字时代青年成人疫情后健康促进行为(PP-HPB)量表的编制与验证
J Multidiscip Healthc. 2023 Aug 25;16:2449-2462. doi: 10.2147/JMDH.S421060. eCollection 2023.
4
Development of a Reflective Ability Scale for Clinical Nurses.临床护士反思能力量表的研制
Yonago Acta Med. 2021 Aug 24;64(3):303-314. doi: 10.33160/yam.2021.08.010. eCollection 2021 Aug.
5
Development and validation of self-management scale for tuberculosis patients.结核病患者自我管理量表的编制与验证。
BMC Infect Dis. 2022 May 27;22(1):502. doi: 10.1186/s12879-022-07483-3.
6
[Development of the Patient Caring Communication Scale].[患者关怀沟通量表的编制]
J Korean Acad Nurs. 2019 Feb;49(1):80-91. doi: 10.4040/jkan.2019.49.1.80.
7
Development and Validation of the Knowledge and Attitude Scale Toward COVID-19 Pandemic Breaking Transmission Chain (KA-C) Among Iranian Population.开发并验证了伊朗人群对 COVID-19 大流行阻断传播链的知识和态度量表(KA-C)。
Front Public Health. 2021 Feb 17;9:627013. doi: 10.3389/fpubh.2021.627013. eCollection 2021.
8
Evaluating the Reliability and Validity of the Korean Version of the Pandemic-Related Pregnancy Stress Scale.评估韩国版大流行相关妊娠压力量表的信度和效度。
Risk Manag Healthc Policy. 2023 Apr 8;16:655-666. doi: 10.2147/RMHP.S401210. eCollection 2023.
9
Developing and Testing the Validity and Reliability of the Brief Adolescent Respiratory System Health Assessment Scale-Student Version in a Chinese Sample.在中国样本中开发并测试青少年呼吸系统健康简易评估量表-学生版的有效性和可靠性。
Front Pediatr. 2021 Aug 17;9:713066. doi: 10.3389/fped.2021.713066. eCollection 2021.
10
Development of Emerging Infectious Diseases Preventive Health Behavior (EID-PHB) Scale and Validation of the Complex Models.新兴传染病预防健康行为(EID-PHB)量表的编制及复杂模型的验证
J Multidiscip Healthc. 2024 Feb 1;17:445-460. doi: 10.2147/JMDH.S446006. eCollection 2024.

引用本文的文献

1
Development of Emerging Infectious Diseases Preventive Health Behavior (EID-PHB) Scale and Validation of the Complex Models.新兴传染病预防健康行为(EID-PHB)量表的编制及复杂模型的验证
J Multidiscip Healthc. 2024 Feb 1;17:445-460. doi: 10.2147/JMDH.S446006. eCollection 2024.
2
Development and Validation of a Scale Measuring the Post Pandemic-Health Promotion Behavior (PP-HPB) of Young Adults in the Digital Era.数字时代青年成人疫情后健康促进行为(PP-HPB)量表的编制与验证
J Multidiscip Healthc. 2023 Aug 25;16:2449-2462. doi: 10.2147/JMDH.S421060. eCollection 2023.

本文引用的文献

1
A Comprehensive Review of the Global Efforts on COVID-19 Vaccine Development.关于全球新冠疫苗研发努力的全面综述
ACS Cent Sci. 2021 Apr 28;7(4):512-533. doi: 10.1021/acscentsci.1c00120. Epub 2021 Mar 29.
2
Predictors of COVID-19 severity: A literature review.预测 COVID-19 严重程度的因素:文献综述。
Rev Med Virol. 2021 Jan;31(1):1-10. doi: 10.1002/rmv.2146. Epub 2020 Jul 30.
3
Lessons from SARS-CoV-2 Pandemic: Evolution, Disease Dynamics and Future.严重急性呼吸综合征冠状病毒2大流行的经验教训:演变、疾病动态与未来
Biology (Basel). 2020 Jun 26;9(6):141. doi: 10.3390/biology9060141.
4
Delivery of infection from asymptomatic carriers of COVID-19 in a familial cluster.COVID-19 无症状感染者在家庭聚集性病例中的传播。
Int J Infect Dis. 2020 May;94:133-138. doi: 10.1016/j.ijid.2020.03.042. Epub 2020 Apr 2.
5
WHO Declares COVID-19 a Pandemic.世界卫生组织宣布新冠疫情为大流行病。
Acta Biomed. 2020 Mar 19;91(1):157-160. doi: 10.23750/abm.v91i1.9397.
6
The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak.冠状病毒病(COVID-19)疫情的流行病学和发病机制。
J Autoimmun. 2020 May;109:102433. doi: 10.1016/j.jaut.2020.102433. Epub 2020 Feb 26.
7
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.